Skye Bioscience, Inc. Common Stock (SKYE) — Capital Reinvestment Ratio

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock (SKYE) has a Capital Reinvestment Ratio of 8.56x as of June 2014, meaning it reinvests 9% of its operating cash flow ($7.92K) in capital expenditures ($67.83K). Check SKYE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

8.56x

Capex / Operating Cash Flow

Operating Cash Flow

$7.92K

USD

Capital Expenditures

$67.83K

USD

Data as of

Jun 2014

Most recent filing

Annual Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock from None to None. See how much free cash does Skye Bioscience, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow